Recurrence Monitoring in NSCLC Using Circulating Tumor DNA

Status unconfirmed

Conditions studied: Non Small Cell Lung Cancer

In brief

This research study is investigating the role of cell free tumor DNA profiling in determining disease relapse and/or progression for patients with advanced NSCLC.

Key facts

Study ID

NCT03878537

Run by

Scripps Translational Science Institute

People needed

50

Starts

2019-03-14

Expected to finish

2021-12-31

Last updated by the study team

2021-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Treatment naïve biopsy confirmed not surgically resectable stage III or greater NSCLC
• Baseline CT imaging available

You may not qualify if…

• Patients unable to undergo biopsy for initial tissue diagnosis
• Patients who do not wish to pursue standard of care therapy
• Patients with another diagnosis of malignancy

Where it is running

• Scripps Health/Scripps Clinic Hillcrest/Scripps Clinic Torrey Pines — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.